(Q34032095)

30 July 2017

title

Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors (English)

1 reference

30 July 2017

Bourgault C

1

1 reference

30 July 2017

Elstein E

series ordinal

2

1 reference

30 July 2017

Le Lorier J

series ordinal

3

1 reference

30 July 2017

Suissa S

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

Canadian Medical Association Journal

30 July 2017

published in

1 reference

30 July 2017

volume

161

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

255-260

1 reference

Formulary management of ACE inhibitors

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

A framework for cost-sharing policy analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Economic impact of cost-containment strategies in third party programmes in the US (part I).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Economic impact of cost-containment strategies in third party programmes in the US. Part II.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Reference-based pricing in British Columbia: implications for cardiologists--an analysis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Clinical and economic effects of replacing enalapril with benazepril in hypertensive patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Opportunity lost: a frontline view of reference-based pricing

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Improving physician prescribing practices: bridge over troubled waters

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Differences in the acute and chronic antihypertensive effects of lisinopril and enalapril assessed by ambulatory blood pressure monitoring

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Critical assessment of ACE inhibitors. Part 2.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Safety and efficacy of chronic therapy with captopril in hypertensive patients: an update

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Generic drug substitution revisited

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Angiotensin converting enzyme inhibitors. Properties and side effects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Saskatchewan health data bases: a developing resource.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalapril

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Angiotensin-converting enzyme inhibitors: past, present, and bright future

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Angiotensin-converting enzyme inhibitors: are they all alike?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Captopril in hypertension; seven years later

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Assessment of the antihypertensive effect of lisinopril using 24-hour ambulatory monitoring

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

The safety and tolerability of lisinopril in clinical trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Angiotensin converting enzyme inhibitors and moderate hypertension

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Lisinopril and enalapril in hypertension: a comparative study using ambulatory monitoring

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Duration of Angiotensin-Converting Enzyme Inhibition: Implications for Tolerability

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Safety of long-term use of lisinopril for congestive heart failure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Recent public policies in The Netherlands to control pharmaceutical pricing and reimbursement.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1230501

Reference-based pricing of prescription drugs

29 October 2018

1 reference

12 December 2020

Coverage of drug costs: reference-based pricing

1 reference

12 December 2020

The Canadian Cardiovascular Society and reference-based drug pricing

1 reference

12 December 2020

Captopril and Enalapril

1 reference

12 December 2020

Resolution of captopril-induced rash after substitution of enalapril

1 reference

12 December 2020

Postmarketing studies of drug efficacy: when must they be randomized?

1 reference

12 December 2020

Conversions from captopril to lisinopril at a dosage ratio of 5:1 result in comparable control of hypertension

1 reference

12 December 2020

Safety and tolerability of lisinopril in older hypertensive patients

1 reference

12 December 2020

Enalapril and lisinopril in the treatment of mild to moderate essential hypertension

1 reference

12 December 2020

Once-daily lisinopril compared with twice-daily captopril in the treatment of mild to moderate hypertension: assessment of office and ambulatory blood pressures

1 reference

12 December 2020

Identifiers

PMC publication ID

1230501

1 reference

30 July 2017

1 reference